Gapping up
In reaction to earnings/guidance:
- GENI +6.5%, VLRS +4.3%, ZTO +3.5%, CPRT +3%, TGI +2.1%, SQM +1.6%, HRL +1.5%, SNPS +1.3%, NGG +0.9%
Other news:
- SPCE +16.8% (confirmed that the next rocket-powered test flight of SpaceShipTwo Unity will be conducted on May 22, pending weather and technical checks)
- ALLO +11.6% (CD19 Forum Highlights Positive Results from Phase 1 Studies of ALLO-501 and ALLO-501A)
- ADAP +11.2% (ASCO-related announcement)
- ONCT +8.6% (ASCO-related announcement)
- IMNM +7.6% (announces additional $4.3 mln award by DOD following positive preclinical testing results on COVID-19 variants of concern)
- MOGO +5.2% (has been granted a Visa Ready certification through its Visa Ready for Fintech Enablers program)
- SNSE +4.8% (announces new Phase 1/2 data for SNS-301)
- GTH +4.6% (announced a strategic partnership with JD Health, a subsidiary of JD.com (JD))
- IOVA +3.5% (ASCO-related announcement)
- DTIL +3.5% (ASCO-related announcement)
- ONCY +3.5% (announces data demonstrating clinical proof-of-concept for pelareorep-checkpoint inhibitor combination therapy in pancreatic cancer)
- CSII +3.4% (reports results from coherence tomography imaging study of coronary OAS patients)
- AVEO +2.9% (ASCO-related announcement)
- AFG +2.5% (to declare special dividend of $12-14/sh)
- CLVS +2.3% (ASCO-related announcement)
- ADCT +2.2% (ASCO-related announcement)
- MEIP +2.2% (ASCO-related announcement)
- RCUS +2.1% (ASCO-related announcement)
- F +1.7% (to launch battery JV with SK Innovation to support EV rollout, according to Reuters)
- BGNE +1.6% (ASCO-related announcement)
- SNY +1.5% (ASCO-related announcement)
Analyst comments:
- HIMS +4.9% (upgraded to Outperform from Neutral at Credit Suisse)
- SHLS +4.2% (upgraded to Buy from Neutral at Goldman)
- CMG +2.8% (upgraded to Buy from Neutral at UBS)
- VIAC +2.8% (upgraded to Buy from Neutral at BofA Securities)
- SEDG +2.4% (upgraded to Buy from Neutral at Goldman)
- DAO +1.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- IR +1.2% (upgraded to Buy from Hold at Deutsche Bank)
- ADI +0.9% (upgraded to Outperform from Mkt Perform at Bernstein)